70
Views
2
CrossRef citations to date
0
Altmetric
Original Research

A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide

, , , , , & show all
Pages 347-360 | Published online: 08 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Beatrice Setnik, Kenneth W. Sommerville, Glenn C. Pixton & Lynn Webster. (2019) Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users. Current Medical Research and Opinion 35:3, pages 503-512.
Read now
Beatrice Setnik, Carl L. Roland, Glenn C. Pixton & Kenneth W. Sommerville. (2017) Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain. Postgraduate Medicine 129:1, pages 5-11.
Read now